EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The Danish national haemoglobinopathy screening programme: Report from 16 years of screening in a low‐prevalence, non‐endemic region

Esther Agnethe Ejskjaer Gravholt iD, Jesper Petersen iD, Mathis Mottelson iD, Amina Nardo-Marino iD, Mathias Rathe iD, Marianne Olsen iD, Charlotte Holm iD, Finn Stener Jørgensen iD, Henrik Birgens, Andreas Glenthøj iD

British Journal of Haematology · 2024

DOI: 10.1111/bjh.19103 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Esther Agnethe Ejskjaer Gravholt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Danish Red Blood Cell Centre, Department of Haematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Hemoglobinopathies. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk Fonden, European Union, European Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Danish national haemoglobinopathy screening programme seeks to determine parental haemoglobinopathy carrier state antenatally. In this retrospective register‐based study, we evaluated the 16‐year trajectory of this programme, utilising the Danish Red Blood Cell Centre's laboratory database, covering approximately 77% of the Danish population. During the study period, we observed a substantial increase in annual diagnostic examinations performed, from 389 in 2007 to 3030 in 2022. Women constituted 88% of these cases, aligning with the emphasis of the screening programme. Of these, 54% of women of reproductive age (15–40 years) and 10% of women >40 years were specified as pregnant. During our study period, 61 children were born with a severe haemoglobinopathy, out of which 23 children were born from mothers not residing in Denmark during their first trimester thus not included in the screening programme. Prenatal invasive testing was performed for 60 fetuses, identifying 12 with homozygous or compound heterozygous haemoglobinopathy. The Danish haemoglobinopathy screening programme has provided screening, information and reproductive choices for numerous families. During the study period, screening for haemoglobinopathies has been steadily increasing and is expected to continue to increase. Awareness of and adherence to the screening programme is subject of further investigation and optimisation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemoglobinopathiesChildPregnancyFemaleHumansAdolescentYoung AdultAdultPrevalenceRetrospective StudiesSurveys and QuestionnairesDenmark

Stichwörter der Autor:innen

haemoglobinopathiessickle cell anaemiasickle cell diseasethalassaemiaβ thalassaemia

Autor:innen und Institutionen

  • Danish Red Blood Cell Centre, Department of Haematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.
  • Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
  • Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Department of Paediatrics and Adolescent Medicine, Aalborg University Hospital, Aalborg, Denmark.
  • Department of Gynaecology and Obstetrics, Copenhagen University Hospital - Amager and Hvidovre, Hvidovre, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Esther Agnethe Ejskjaer Gravholt, Jesper Petersen, Mathis Mottelson, Amina Nardo-Marino, Mathias Rathe, Marianne Olsen, Charlotte Holm, Finn Stener Jørgensen, Andreas Glenthøj

Förderung

  • Novo Nordisk Fonden
  • European Union
  • European Commission

Zitieren

APA

Gravholt, E. A. E., Petersen, J., Mottelson, M., Nardo-Marino, A., Rathe, M., Olsen, M., Holm, C., Jørgensen, F. S., Birgens, H., & Glenthøj, A. (2024). The Danish national haemoglobinopathy screening programme: Report from 16 years of screening in a low‐prevalence, non‐endemic region. British Journal of Haematology. https://doi.org/10.1111/bjh.19103

Vancouver

Gravholt EAE, Petersen J, Mottelson M, Nardo-Marino A, Rathe M, Olsen M, et al. The Danish national haemoglobinopathy screening programme: Report from 16 years of screening in a low‐prevalence, non‐endemic region. British Journal of Haematology. 2024. doi:10.1111/bjh.19103

BibTeX
@article{Gravholt2024,
  author = {Gravholt, Esther Agnethe Ejskjaer and Petersen, Jesper and Mottelson, Mathis and Nardo-Marino, Amina and Rathe, Mathias and Olsen, Marianne and Holm, Charlotte and Jørgensen, Finn Stener and Birgens, Henrik and Glenthøj, Andreas},
  title = {The Danish national haemoglobinopathy screening programme: Report from 16 years of screening in a low‐prevalence, non‐endemic region},
  journal = {British Journal of Haematology},
  year = {2024},
  doi = {10.1111/bjh.19103}
}
Kostenlos starten →